Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Other Accumulated Expenses (2024 - 2026)

Mesoblast's (MEOBF) quarterly Other Accumulated Expenses came in at $7.4 million in Q2 2026, down 31.84% year-over-year from $10.8 million in Q2 2025, and down 33.31% quarter-over-quarter from $11.0 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

Mesoblast has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $7.4 million for Q2 2026.

  • In Q2 2026, Other Accumulated Expenses fell 31.84% year-over-year to $7.4 million; the TTM figure through Jun 2026 stood at $7.4 million (down 31.84% YoY), while the FY2026 annual figure was $7.4 million, down 31.84% from the prior year.
  • Other Accumulated Expenses came in at $7.4 million for Q2 2026 at Mesoblast, down from $11.0 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $11.0 million in Q4 2025 to a low of $7.4 million in Q2 2026.
  • Average Other Accumulated Expenses over 3 years is $9.9 million, with a median of $10.7 million recorded in 2024.
  • Year-over-year, Other Accumulated Expenses grew 1.63% in 2025 and slumped 31.84% in 2026.
  • Over 3 years, Other Accumulated Expenses stood at $10.6 million in 2024, then advanced by 3.86% to $11.0 million in 2025, then tumbled by 33.31% to $7.4 million in 2026.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $7.4 million in Q2 2026, $11.0 million in Q4 2025, and $10.8 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn
10 Mesoblast 246.02 Mn 143.11 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.36 Mn
Dec 31, 2025 11.03 Mn
Jun 30, 2025 10.79 Mn
Jun 30, 2024 10.62 Mn